Yeonsoo Baik
Datos Biográficos
| ID | 9064141 |
|---|---|
| NOMBRE | Yeonsoo Baik |
| NOMBRES | Yeonsoo |
| APELLIDO | Baik |
| FIRMA | BAIK Y |
| AFILIACIONES | Johns Hopkins University |
| ORCID | 0000-0001-7016-0438 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2024 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2024 |
| ÍNDICE H | 0 |
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda
Three months of isoniazid-rifapentine (3HP) is being scaled up for tuberculosis (TB) preventive treatment (TPT) among people living with HIV (PLHIV) in high-burden settings. More evidence is needed to identify factors influencing successful 3HP delivery. We conducted a qualitative assessment of 3HP delivery nested within the 3HP Options Trial, which compared three optimized strategies for delivering 3HP: facilitated directly observed therapy (DOT…
Sin obras prominentes en esta página.
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda
Three months of isoniazid-rifapentine (3HP) is being scaled up for tuberculosis (TB) preventive treatment (TPT) among people living with HIV (PLHIV) in high-burden settings. More evidence is needed to identify factors influencing successful 3HP delivery. We conducted a qualitative assessment of 3HP delivery nested within the 3HP Options Trial, which compared three optimized strategies for delivering 3HP: facilitated directly observed therapy (DOT…
Dosing (1 obras) · Family medicine (1 obras) · Internal Medicine (1 obras) · Latent tuberculosis (1 obras) · Medicine (1 obras) · Pneumocystis jirovecii pneumonia detection and treatment (1 obras) · Pneumonia and Respiratory Infections (1 obras) · Qualitative research (1 obras) · Rifapentine (1 obras) · Thematic analysis (1 obras)